Olaris announces findings from exploratory analysis of biomarkers that predict patient responsiveness to Trastuzumab therapy

Add some more info about this item...

Olaris, Inc

35 Gatehouse Drive

Waltham, Massachusetts

02451

e: info@olarisBoR.com

  • Grey LinkedIn Icon
  • Grey Facebook Icon
  • Twitter

© 2021 Olaris, Inc